{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:25:06Z","timestamp":1790807106013,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.leukres.2017.03.009","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T22:30:22Z","timestamp":1489703422000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Clinical relevance of TP53 polymorphic genetic variations in chronic lymphocytic leukemia"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9336-4767","authenticated-orcid":false,"given":"Nadiia","family":"Bilous","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iryna","family":"Abramenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Saenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatoliy","family":"Chumak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iryna","family":"Dyagil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoya","family":"Martina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iryna","family":"Kryachok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.leukres.2017.03.009_bib0005","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrc2723","article-title":"The first 30 years of p53: growing ever more complex","volume":"9","author":"Levine","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.leukres.2017.03.009_bib0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10689-016-9931-3","article-title":"Mutational analysis of TP53 gene in Tunisian familial hematological malignancies and sporadic acute leukemia cases","volume":"16","author":"Hamadou","year":"2017","journal-title":"Fam. Cancer"},{"issue":"6","key":"10.1016\/j.leukres.2017.03.009_bib0015","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/IGC.0000000000000725","article-title":"The association between p53 codon 72 polymorphism and endometrial cancer risk: a system review and meta-analysis","volume":"26","author":"Yi","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.leukres.2017.03.009_bib0020","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/mutage\/ger067","article-title":"Mutations and polymorphisms in TP53 gene \u2013 an overview on the role in colorectal cancer","volume":"27","author":"Naccarati","year":"2012","journal-title":"Mutagenesis"},{"issue":"6","key":"10.1016\/j.leukres.2017.03.009_bib0025","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.1007\/s13277-015-4612-7","article-title":"Breast cancer risk in relation to TP53 codon 72 and CDH1 gene polymorphisms in the Bangladeshi women","volume":"37","author":"Shabnaz","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.leukres.2017.03.009_bib0030","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1038\/bcj.2015.11","article-title":"The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes","volume":"5","author":"McGraw","year":"2015","journal-title":"Blood Cancer J."},{"issue":"4","key":"10.1016\/j.leukres.2017.03.009_bib0035","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s12032-014-0908-5","article-title":"TP53 Pro72 allele potentially increases the poor prognostic significance of TP53 mutation in chronic lymphocytic leukemia","volume":"31","author":"Dong","year":"2014","journal-title":"Med. Oncol."},{"issue":"7","key":"10.1016\/j.leukres.2017.03.009_bib0040","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv101","article-title":"Germline TP53 variants and susceptibility to osteosarcoma","volume":"107","author":"Mirabello","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.leukres.2017.03.009_bib0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.yexmp.2010.11.002","article-title":"TP53 polymorphisms in gliomas from Indian patients: study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3","volume":"90","author":"Jha","year":"2011","journal-title":"Exp. Mol. Pathol."},{"issue":"10","key":"10.1016\/j.leukres.2017.03.009_bib0050","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/carcin\/bgv164","article-title":"The presence of the intron 3 16bp duplication polymorphism of p53 (rs17878362) in breast cancer is associated with a low \u039440p53:p53 ratio and better outcome","volume":"37","author":"Morten","year":"2016","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1016\/j.leukres.2017.03.009_bib0055","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1134\/S0026893314050173","article-title":"Linkage disequilibrium and haplotypes of rs1042522, rs1625895 and rs17878362 gene TP53 markers in patients with diffuse large B-cell lymphoma","volume":"48","author":"Voropaeva","year":"2014","journal-title":"Mol. Biol. (Mosk)"},{"issue":"3","key":"10.1016\/j.leukres.2017.03.009_bib0060","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/mutage\/get008","article-title":"Differential mutation profiles and similar intronic TP53 polymorphisms in asbestos-related lung cancer and pleural mesothelioma","volume":"28","author":"Andujar","year":"2013","journal-title":"Mutagenesis"},{"issue":"9","key":"10.1016\/j.leukres.2017.03.009_bib0065","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.leukres.2005.12.014","article-title":"Two germ line polymorphisms of the tumour suppressor gene p53 may influence the biology of chronic lymphocytic leukaemia","volume":"30","author":"Kochethu","year":"2006","journal-title":"Leuk. Res."},{"issue":"4","key":"10.1016\/j.leukres.2017.03.009_bib0070","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.leukres.2007.08.013","article-title":"Chronic lymphocytic leukemia patients exposed to ionizing radiation due to the Chernobyl NPP accident \u2013 with focus on immunoglobulin heavy chain gene analysis","volume":"32","author":"Abramenko","year":"2008","journal-title":"Leuk. Res."},{"issue":"14","key":"10.1016\/j.leukres.2017.03.009_bib0075","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1158\/1078-0432.CCR-07-0609","article-title":"MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma","volume":"13","author":"Hirata","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"7571","key":"10.1016\/j.leukres.2017.03.009_bib0080","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Genomes Project Consortium","year":"2015","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.leukres.2017.03.009_bib0085","doi-asserted-by":"crossref","first-page":"e0134463","DOI":"10.1371\/journal.pone.0134463","article-title":"Genotype and haplotype analyses of TP53 gene in breast cancer patients: association with risk and clinical outcomes","volume":"10","author":"Vymetalkova","year":"2015","journal-title":"PLos One"},{"key":"10.1016\/j.leukres.2017.03.009_bib0090","unstructured":"NHLBI GO Exome Sequencing Project (ESP), Seattle, WA, URL:http:\/\/evs.gs.washington.edu\/EVS\/. (Accessed: April, 2015)."},{"issue":"2","key":"10.1016\/j.leukres.2017.03.009_bib0095","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.leukres.2017.03.009_bib0100","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1158\/1078-0432.CCR-08-1630","article-title":"The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness","volume":"15","author":"Rossi","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"26","key":"10.1016\/j.leukres.2017.03.009_bib0105","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1182\/blood-2009-07-234708","article-title":"Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage","volume":"114","author":"Malcikova","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2017.03.009_bib0110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/bjh.13933","article-title":"The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience","volume":"173","author":"Van Dyke","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2017.03.009_bib0115","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1186\/2193-1801-3-749","article-title":"Association of the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis","volume":"3","author":"Gon\u00e7alves","year":"2014","journal-title":"Springerplus"},{"issue":"3","key":"10.1016\/j.leukres.2017.03.009_bib0120","doi-asserted-by":"crossref","first-page":"9024","DOI":"10.4238\/2015.August.7.11","article-title":"Association of the p53 Arg72Pro polymorphism with esophageal cancer in Chinese populations: a meta-analysis","volume":"14","author":"Peng","year":"2015","journal-title":"Genet. Mol. Res."},{"issue":"6","key":"10.1016\/j.leukres.2017.03.009_bib0125","first-page":"9055","article-title":"TP53 codon 72 polymorphism and susceptibility to cervical cancer in the Chinese population: an update meta-analysis","volume":"8","author":"Li","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"3","key":"10.1016\/j.leukres.2017.03.009_bib0130","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s10120-011-0034-4","article-title":"p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population","volume":"14","author":"Song","year":"2011","journal-title":"Gastric Cancer"},{"issue":"38","key":"10.1016\/j.leukres.2017.03.009_bib0135","doi-asserted-by":"crossref","first-page":"e1588","DOI":"10.1097\/MD.0000000000001588","article-title":"The role of TP53 gene codon 72 polymorphism in leukemia: a PRISMA-compliant systematic review and meta-analysis","volume":"94","author":"Ruan","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.leukres.2017.03.009_bib0140","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s12253-014-9867-6","article-title":"TP53 Arg 72Pro and MDM2 SNP309 polymorphisms and colorectal cancer risk: a west Algerian population study","volume":"21","author":"Abderrahmane","year":"2015","journal-title":"Pathol. Oncol. Res."},{"issue":"3","key":"10.1016\/j.leukres.2017.03.009_bib0145","first-page":"3120","article-title":"The TP53 codon 72 Pro\/Pro genotype may be associated with an increased lung cancer risk in North China: an updated meta-analysis","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"24","key":"10.1016\/j.leukres.2017.03.009_bib0150","doi-asserted-by":"crossref","first-page":"10653","DOI":"10.7314\/APJCP.2014.15.24.10653","article-title":"Association of a p53 codon 72 gene polymorphism with environmental factors and risk of lung cancer: a case control study in Mizoram and Manipur, a high incidence region in North East India","volume":"15","author":"Saikia","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"12","key":"10.1016\/j.leukres.2017.03.009_bib0155","doi-asserted-by":"crossref","first-page":"9995","DOI":"10.1007\/s13277-015-3795-2","article-title":"TLR2\u039422 (-196-174) significantly increases the risk of breast cancer in females carrying proline allele at codon 72 of TP53 gene: a case-control study from four ethnic groups of North Eastern region of India","volume":"36","author":"Devi","year":"2015","journal-title":"Tumour Biol."},{"issue":"2","key":"10.1016\/j.leukres.2017.03.009_bib0160","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1158\/1055-9965.EPI-06-0790","article-title":"Common genetic variation in TP53 is associated with lung cancer risk and prognosis in African Americans and somatic mutations in lung tumors","volume":"16","author":"Mechanic","year":"2007","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"1","key":"10.1016\/j.leukres.2017.03.009_bib0165","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/pbc.21077","article-title":"National Osteosarcoma Etiology study group. Germ-line genetic variation of TP53 in osteosarcoma","volume":"49","author":"Savage","year":"2007","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.leukres.2017.03.009_bib0170","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/978-1-4614-8051-8_13","article-title":"Inherited susceptibility to CLL","volume":"792","author":"Speedy","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"issue":"21","key":"10.1016\/j.leukres.2017.03.009_bib0175","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1182\/blood.V118.21.1783.1783","article-title":"The TP53 codon72 polymorphism is associated with TP53 mutations in chronic lymphocytic leukemia","volume":"118","author":"Grossmann","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2017.03.009_bib0180","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3324\/haematol.13533","article-title":"Clinical relevance of MDM2 SNP 309 and TP53 Arg72Pro in follicular lymphoma","volume":"94","author":"Wrench","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2017.03.009_bib0185","doi-asserted-by":"crossref","first-page":"435983","DOI":"10.1155\/2014\/435983","article-title":"Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we go","volume":"2014","author":"Puiggros","year":"2014","journal-title":"Biomed. Res. Int."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617300851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617300851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T00:56:19Z","timestamp":1601772979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212617300851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":37,"alternative-id":["S0145212617300851"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2017.03.009","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical relevance of TP53 polymorphic genetic variations in chronic lymphocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2017.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}